Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Top Financings: 2018 Was A Remarkable Year For Biopharma Fundraising

Jan 09 2019

• By Mandy Jackson

stock

Related Content

EU Accelerated Assessment Tracker: First Filing From Bluebird And Daiichi Keeping Mum

Oct 08 2018

Sage's Oral GABA-A Modulator Shows 'Dramatic' Effect On Depression

Dec 08 2017

Can Editas, BeiGene Offerings Redeem US IPO Class Of 2015?

Feb 04 2016

Off The Clock? The New Timelines Of “Real-Time Review”

Nov 27 2018

Celgene Eyes IO Growth With BeiGene China Pact

Jul 06 2017

Gilead Makes Cell Therapy The Base Of Its Oncology Platform With Kite Buy

Aug 29 2017

Strong Innovent IPO Restoring Faith In HK Biotech Listings?

Oct 31 2018

ECHELON-2 Ushers In Another New Adcetris Indication For Seattle Genetics

Oct 01 2018

Finance Watch: With The Year's Biggest IPO, CFO Says Allogene Is Ready To Go 'Full Throttle'

Oct 12 2018

Cerevel Launches With Pfizer's Early CNS Assets And $350m From Bain Capital

Oct 23 2018

Seattle Genetics Diversifies Beyond ADCs With Cascadian Acquisition

Jan 31 2018

Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases

Jan 23 2018

Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing

Apr 03 2018

Finance Watch: Three New Funds, Including Former Amgen R&D Head Harper's Next Venture

Sep 07 2018

Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway

May 03 2018

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

Jul 16 2018

Tibsovo Approval Makes Agios’ Second AML Approval In A Year; Priced At $26k For 30 Days

Jul 20 2018

Poseida, Legend/Janssen Look To Snag Celgene/Bluebird's BCMA Crown

Dec 04 2018

Few Signs Of An IPO Slowdown Despite US Biotech Stock Slump

Nov 20 2018

Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend

Feb 05 2018

Sage Gets More Time For Zulresso Launch Preparations With Delay Of US FDA Approval

Nov 21 2018

Finance Watch: Investments In Regenerative Therapies Surged In The Second Quarter

Aug 11 2018

Finance Watch: Rakuten Aspyrian Raises $150m VC Round For Laser-Activated Cancer Drugs

Aug 24 2018

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Mar 09 2018

Related Companies

BeOne Medicines Ltd.

Moderna, Inc.

Allogene Therapeutics Inc.

Kite Pharma, Inc.

Bristol Myers Squibb Company

Innovent Biologics, Inc.

Ascletis Pharma, Inc.

Gilead Sciences, Inc.

Biosplice Therapeutics, Inc.

Pfizer Inc.

Cerevel Therapeutics Holdings, Inc.

Rakuten Medical, Inc.

Seagen Inc.

Cascadian Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Genetix Biotherapeutics

Sage Therapeutics, Inc.

Agios Pharmaceuticals, Inc.

Additional Topics

Financing Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window